Cite
HARVARD Citation
Weng, Z. et al. (2022). Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in MYCN-amplified neuroblastoma. Neuro-oncology. 24 (6), pp. 872-885. [Online].